These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10593431)

  • 1. Monocyte tissue factor response is decreased in patients with hyperlipidemia.
    Rugeri L; Susen S; Bard JM; Corseaux D; Gavériaux V; Devos P; Lecerf JM; Duriez P; Jude B
    Thromb Res; 1999 Nov; 96(4):283-92. PubMed ID: 10593431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide.
    Nguyên P; Broussas M; Cornillet-Lefèbvre P; Potron G
    Transfusion; 1999 Sep; 39(9):975-82. PubMed ID: 10533824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.
    Vambergue A; Rugeri L; Gaveriaux V; Devos P; Martin A; Fermon C; Fontaine P; Jude B
    Thromb Res; 2001 Mar; 101(5):367-75. PubMed ID: 11297753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
    El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
    Hansen JB; Grimsgaard S; Huseby N; Sandset PM; Bønaa KH
    Thromb Res; 2001 Apr; 102(1):3-13. PubMed ID: 11323009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
    Bajaj MS; Ghosh M; Bajaj SP
    J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation.
    McGee MP; Foster S; Wang X
    J Exp Med; 1994 Jun; 179(6):1847-54. PubMed ID: 8195712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
    Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
    Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK; Song KS; Park YS; Yun YS; Shim WH
    Cardiology; 2000; 93(1-2):31-6. PubMed ID: 10894904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester.
    van der Logt CP; Dirven RJ; Reitsma PH; Bertina RM
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):211-20. PubMed ID: 8054453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
    Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1.
    Ott I; Andrassy M; Zieglgänsberger D; Geith S; Schömig A; Neumann FJ
    Blood; 2001 Jun; 97(12):3721-6. PubMed ID: 11389008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes.
    Osterud B; Rao LV; Olsen JO
    Thromb Haemost; 2000 Jun; 83(6):861-7. PubMed ID: 10896239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
    Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I
    Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.